5Kantarjian H,Sawyers C,Hochhaus A,et al.Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia[].The New England Journal of Medicine.2002
6Druker BJ,Lydon NB.Lesssons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia[].The Journal of Clinical Investigation.2000
7Sawyers CL,Hochhaus A,Feld E,et al.Imatinib induces hematologic and cytogenetic responses in patients with chronic myeloid leukemia in myeloid blast crisis: results of a phase II study[].Blood.2002
8Talpaz M,Silver RT,Druker BJ,et al.Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study[].Blood.2002
9Carroll M,Ohno-Jones S,Tamura S,et al.CGP57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL and TEL-PDGFR fusion proteins[].Blood.1997
10Bass DA,Parce W,Lawrence R,et al.Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation[].J Immunol.1983
